1. The current role of thiazolidinediones in diabetes management
   Christos V. Rizos et al, 2016, Archives of Toxicology CrossRef
2. Effect of hyperbaric oxygen on post-stroke depression
   Hong Guo et al, 2023, World Journal of Psychiatry CrossRef
3. Investigating the pro-cognitive and anti-depressant efficacy of metformin: A systematic review and meta-analysis of randomised controlled trials
   Anjan Nibber et al, 2022, Journal of Affective Disorders CrossRef
4. Novel Therapeutics in Bipolar Disorder
   Sabrina C. da Costa et al, 2018, Current Treatment Options in Psychiatry CrossRef
5. Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review
   Young Sup Woo et al, 2020, International Journal of Molecular Sciences CrossRef
6. Genetic Overlap Between Depression and Cardiometabolic Disorders
   Azmeraw T. Amare et al, 2016, Cardiovascular Diseases and Depression CrossRef
7. Risk factors for depression in elderly diabetic patients and the effect of metformin on the condition
   Fenqin Chen et al, 2019, BMC Public Health CrossRef
8. Impact of prediabetes on poststroke depression in Chinese patients with acute ischemic stroke
   Meijuan Xiao et al, 2018, International Journal of Geriatric Psychiatry CrossRef
9. Repositioning of diabetes treatments for depressive symptoms: A systematic review and meta-analysis of clinical trials
   Calum D. Moulton et al, 2018, Psychoneuroendocrinology CrossRef
10. Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders
    Nuojin Li et al, 2022, International Journal of Molecular Sciences CrossRef
11. Association of metformin and depression in patients with type 2 diabetes
    Huan Yu et al, 2022, Journal of Affective Disorders CrossRef
12. Are the antidepressant effects of insulin-sensitizing medications related to improvements in metabolic markers?
    Temi Toba-Oluboka et al, 2022, Translational Psychiatry CrossRef
13. Antidepressant activity of anti-hyperglycemic agents in experimental models: A review
    Nariman Essmat et al, 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews CrossRef
14. Inflammation and the Silent Sequelae of Stroke
    Kyra J. Becker, 2016, Neurotherapeutics CrossRef
15. Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study
    Lars Vedel Kessing et al, 2020, Diabetes Care CrossRef
16. Decreased efficacy of the ketamine and scopolamine-induced sustained antidepressant-like effects in rats receiving metformin
    Han-Wen Chuang et al, 2022, Pharmacological Reports CrossRef
17. Assessment of cognitive impairment and depressive signs in patients with type 2 diabetes treated with metformin from Southeast Mexico: A cross-sectional study
    German Alberto Nolasco-Rosales et al, 2023, Journal of Psychiatric Research CrossRef
18. Steroid receptor RNA activator affects the development of poststroke depression by regulating the peroxisome proliferator-activated receptor γ signaling pathway
    Baoying Jiang et al, 2020, NeuroReport CrossRef
19. Advances in antidepressants for treating post-stroke depression
    Stefano Paolucci, 2017, Expert Opinion on Pharmacotherapy CrossRef
20. Pharmacological management of post-stroke depression
    Luis Castilla-Guerra et al, 2020, Expert Review of Neurotherapeutics CrossRef
21. Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease
    Mervin Chávez-Castillo et al, 2020, Current Neuropharmacology CrossRef
22. Shared metabolic and neuroimmune mechanisms underlying Type 2 Diabetes Mellitus and Major Depressive Disorder
    Eduardo Duarte-Silva et al, 2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry CrossRef
23. Régimes hyperlipidiques et dépression
    Sébastien Bullich et al, 2022, Cahiers de Nutrition et de Diététique CrossRef